| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.66 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |